|
|
||||||||
1 From the Department of Ophthalmology, Casey Eye Institute 2 Departments of Cell and Developmental Biology and 4 Medicine, Oregon Health Sciences University, Portland.
| Abstract |
|---|
|
|
|---|
METHODS. Endothelial cells from collagenase-digested irises were isolated on the basis of their expression of platelet endothelial cell adhesion molecule (PECAM)-1, using antibody-coupled magnetic beads. Cells were characterized as endothelial based on morphologic criteria, their expression of PECAM-1 and von Willebrand factor, their uptake of acetylated low-density lipoprotein, and their ability to form capillary-like networks on a synthetic basement membrane. Constitutive and inflammatory agentmodulated expression of ICAM-1 and -2, VCAM-1, and E-selectin was evaluated by the reverse transcriptionpolymerase chain reaction, enzyme-linked immunocellular assays (ELICAs), Western blot analysis, and functional studies of leukocyte adhesion to HIEC monolayers.
RESULTS. HIECs constitutively expressed mRNA and protein for ICAM-1 and -2, but
only low to nondetectable levels of VCAM-1 or E-selectin. When
stimulated with endotoxin- or tumor necrosis factor (TNF)-
, ICAM-1,
VCAM-1, and E-selectin were potently and time- and dose-dependently
upregulated at both the message and protein levels. By contrast, ICAM-2
message and protein were slowly downregulated by inflammatory agents
over time, but nonetheless remained present and functional. Overall,
cytokine- or endotoxin-activation of HIECs resulted in enhanced
adhesiveness for leukocytes.
CONCLUSIONS. ICAM-1, VCAM-1, and E-selectin have been previously implicated in mediating anterior ocular inflammation. This is a report of the selective isolation of HIECs, with a demonstration of differential expression and regulation of these adhesion molecules in them. In addition, this is the first demonstration of the regulated expression of ICAM-2 in any ocular microvascular cells.
| Introduction |
|---|
|
|
|---|
Given the limitations of investigating the molecular mechanisms of AU directly in human subjects, a variety of animal models of ocular inflammation have been developed, including endotoxin-induced uveitis (EIU), experimental autoimmune uveoretinitis (EAU), experimental melanin-induced uveitis, and experimental autoimmune encephalomyelitis.1 2 These models attempt to mimic human disease and have provided important insights into the cause of AU. Nonetheless, species differences often make it difficult to translate the findings directly from these animal studies over to the human condition. Tissue culture systems provide another means to investigate the biology of ocular inflammation, and others have previously isolated and cultured human choroid and retinal ECs for this purpose.5 6 Functional heterogeneity is known to exist among cultured ECs derived from the microvasculature of different, often proximally situated, tissues.7 8 9 10 Thus, to evaluate microvascular involvement in AU in an in vitro system, we developed a methodology to selectively culture human iris endothelial cells (HIECs).
In this report we provide the initial characterization of cultured HIECs and describe the constitutive and inflammatory agent-regulated expression of several cell adhesion molecules (CAMs) in HIECs. These molecules are likely key mediators of the leukocyte infiltration observed in AU. Leukocyte adhesion assays suggest that in addition to intercellular adhesion molecule (ICAM)-1 and vascular adhesion molecule (VCAM)-1, both of which have been previously implicated in ocular inflammation, ICAM-2 also has the potential to play an important role in leukocyte extravasation through the iris microvascular wall in uveitis.
| Methods |
|---|
|
|
|---|
Confirmation of the EC Nature of Cultured Cells
After one or two rounds of magnetic separation, cultures were
99.5% or more pure on the basis of PECAM-1 and von Willebrand factor
(vWF) expression,7
11
and uptake of
1,1'-dioctacecyl-1,3,3,3',3-tetramethyl-indocarbocyanine perchlorate
acetylated-LDL (DiI-Ac-LDL).12
In specialized culture
conditions with a provisional extracellular matrix, monolayers of ECs
are capable of reorganizing into capillary-like
networks.13
HIECs (75,000) were plated on polymerized
synthetic basement membrane (14.1 mg/ml, 200 µl/well; Matrigel; BD
Biosciences, Bedford, MA) within 24-well tissue culture plates, and
were allowed to attach overnight. Cells were then refed, with some
wells receiving 10 ng/ml phorbol myristate acetate (PMA; Sigma) to
induce tube formation.14
RT-PCR Analysis of Adhesion Molecule mRNA Expression
Confluent HIEC monolayers were stimulated for up to 21 hours
with either lipopolysaccharide (LPS, 10 µg/ml, from Escherichia
coli 055:B5; List Biological Laboratories) or recombinant human
tumor necrosis factor-alpha (TNF
, 10 ng/ml; R&D Systems,
Minneapolis, MN). Total RNA was extracted using a commercial kit
(RNApure; GenHunter Corp., Nashville, TN). Touchdown RT-PCR detection
of gene expression was performed as previously described in
detail.15
Positive control total RNA was obtained from
synovial samples from patients with rheumatoid arthritis. Diethyl
pyrocarbonate-treated water (DEPC-H2O; Ambion,
Inc., Austin, TX) was used as a negative control. Human ICAM-1 primer
sets (sense, 5'-CCGGAAGGTGTATGAACTG-3'; antisense,
5'-TCCATGGTGATCTCTCCTC-3'), ICAM-2 primer sets (sense,
5'-CCGTGGCAATGAGACTCTGCACTA-3'; antisense,
5'-ATGGTTGCTATGGCCGGAAGG-3'), and VCAM-1 primer sets (sense,
5'-CTCCGTCTCATTGACTTGC-3'; antisense, 5'GAACAGGTCATGGTCACAG-3', all
from Operon Technologies, Alameda, CA) were used to probe cDNAs reverse
transcribed from the experimental, positive, and negative control RNA
samples. A primer pair for cyclophilin was included in each assay as an
internal control (sense, 5'-TGTTCTTCGACATTGCCGTCGAC-3'; antisense,
5'-GCATTTGCCATGGACAAGATGCCAGGA-3'; Operon). PCR reaction products were
electrophoresed in 3% agarose gels in Tris-acetate buffer containing
ethidium bromide, and UV-induced fluorescent bands were photographed
and digitized.
Protein Analysis
CAM protein expression on intact monolayers of HIECs was
evaluated using a fluorescence enzyme-linked immunocellular assay
(ELICA) in a 96-well microtiter plate format, as previously described
in detail.16
Mouse monoclonal anti-human ICAM-1 antibody
(Clone W-CAM-1; Neomarkers, Inc., Fremont, CA) rabbit polyclonal
anti-ICAM-2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA),
monoclonal anti-human VCAM-1 antibody (clone BBIG-V1-4B2; R&D Systems),
and monoclonal anti-human E-selectin antibody (clone BBIG-E4-5D11; R&D
Systems) were used as primary detection antibodies (all diluted to 1
µg/ml in 1% bovine serum albumin-bicarbonate-buffered saline).
Affinity-purified, alkaline phosphatase-conjugated goat anti-mouse or
anti-rabbit polyclonal antibodies (1:1000; Sigma) were used for
secondary detection. Methylumbelliferyl phosphate (100 µg/ml; Sigma)
was used as the fluorescence detection substrate. In some cases, ELICA
results were confirmed by Western blot analysis in which HIEC lysates
(3 x 104 cells/lane) were electrophoresed
on 4% to 15% linear gradient SDS-PAGE gels, followed by transfer to
nitrocellulose and protein detection with the same antibodies used in
the ELICA. Bands were visualized using an nitro blue tetrazolium
chloride (NBT)/5-bromo-4-chloro-3-indoyl phosphate (BCIP) detection kit
(Vector Laboratories, Burlingame, CA), and images were digitized.
Leukocyte Adhesion Studies
To explore the utility of our cell culture as an in vitro model
of ocular inflammation, we tested the ability of activated HIEC
cultures to bind U937 monocytes (American Type Culture Collection
[ATCC], Rockville, MD). HIECs were grown to confluence in 48-well
plates and were then stimulated with LPS (10 µg/ml), TNF
(10
ng/ml) or vascular endothelial growth factor (VEGF; 100 ng/ml, R&D
Systems) for 12 hours. In some cases, LPS-stimulated HIECs were
incubated with anti-ICAM-1 mAb (20 µg/ml), anti-ICAM-2 pAb (10
µg/ml), or anti-VCAM-1 mAb (10 µg/ml, Clone 1G11.B1; Neomarkers
Inc.) for the last 30 minutes before monocyte addition. All
stimulations and antibody incubations were performed in complete medium
at 37°C. After EC treatments, the wells were aspirated, quickly
washed with medium MCDB-131 with 10% FBS, and 500 µl of the same
medium containing 2.5 x 105 monocytes was
added to each well and incubated for 15 minutes at 37°C. After
unbound monocytes were gently washed off, the EC monolayers and
adherent monocytes were briefly fixed with 0.5% glutaraldehyde, and
attached monocytes were visually counted (four
1-mm2 regions per well).
Statistical Analysis
Data presented for ELICA and monocyte adhesion assays represent
mean fluorescence per well and monocytes bound per square millimeter of
HIEC monolayer surface area, respectively, ± SD for the indicated
number of replicates. An asterisk in the figures indicates a
significant difference (P < 0.05) between the means of
experimental and respective control groups, by ANOVA (SigmaStat, ver.
2.0 software; SPSS Science, Chicago, IL).
| Results |
|---|
|
|
|---|
70%80%) when recovered from cryopreservation.
|
CAM mRNA Expression in HIECs
By RT-PCR, cultured HIECs were tested for steady state mRNA
expression of various CAMs in response to the inflammatory mediators
LPS and/or TNF-
. Unstimulated HIECs constitutively expressed low but
detectable levels of ICAM-1 message (Fig. 2)
. Stimulation with 10 µg/ml LPS caused a time-dependent upregulation
of ICAM-1 mRNAan effect obvious at 1.5 hours after exposure, maximal
at approximately 3 to 5 hours, and maintained through at least 21 hours
of continuous stimulation. Similar kinetics of ICAM-1 upregulation were
observed when HIECs were stimulated with 10 ng/ml TNF
or
with 10 ng/ml IL-1
(not shown). We also evaluated ICAM-2 mRNA
expression in these cells by RT-PCR (Fig. 2) . We detected significant
constitutively expressed ICAM-2 mRNA in HIECs, which was not measurably
altered by inflammatory agent stimulation. Only barely detectable
VCAM-1 signals (Fig. 2) were seen in unstimulated HIECs. After
activation with LPS or TNF
, however, there was a rapid
upregulation of VCAM-1 message that declined after 21 hours of
stimulation.
|
stimulation (Fig. 3A)
. Upregulated ICAM-1 reached maximal levels after 8 to 12 hours of LPS
or TNF
stimulation and remained maximally elevated through at least
2 days of continued stimulation. ICAM-1 upregulation by LPS was
confirmed by Western blot analysis of HIEC lysates (Fig. 3A
, inset). We
also detected significant constitutive expression of ICAM-2 protein in
HIECs (Fig. 3B)
, which, conversely, was decreased in TNF
- and
LPS-stimulated HIECs. This trend appeared as early as 6 hours after
stimulation and by 24 hours had culminated in a significant 50%
decrease in immunodetectable ICAM-2 on HIEC surfaces. Unlike the clear
constitutive expression of ICAM-1 and -2, only very low levels of
VCAM-1 and no E-selectin protein were detected on unstimulated HIECs.
In response to either LPS or TNF
stimulation, however, VCAM-1
protein was markedly elevated by 6 hours (Fig. 3C)
. After 24 hours of
stimulation, VCAM-1 in TNF
stimulated ECs had begun declining
toward baseline but was still significantly elevated compared with
levels in unstimulated control cultures. After 24 hours of stimulation
with LPS, VCAM-1 protein had already decayed to control levels (Fig. 3C)
, in good temporal concordance with the declining VCAM mRNA signal
observed in these cells. In the case of E-selectin, upregulation by LPS
was rapid, with maximal protein levels detected on HIEC surfaces after
only 4 hours stimulation (Fig. 3D)
. This was followed by a similarly
rapid decline to control levels after only 12 hours.
|
|
| Discussion |
|---|
|
|
|---|
We evaluated in HIECs the expression of three adhesion molecules of the
immunoglobulin superfamily (ICAM-1 and -2 and VCAM-1), and one member
of the selectin family (E-selectin), all of which are known to support
leukocyte adhesion. Consistent with previous demonstrations in other EC
types,16
these cells display a low but measurable
constitutive expression of ICAM-1 that is markedly upregulated at both
the mRNA and the protein levels by stimulation with either LPS or, more
potently, by TNF
. By contrast, constitutively expressed ICAM-2
protein is markedly downregulated by the same inflammatory stimuli over
the same period. That we did not detect a coordinate decrease in ICAM-2
mRNA levels using a multiplex RT-PCR assay was probably due to the
semiquantitative nature of this method, because in preliminary
experiments using gene array hybridization assays we saw an approximate
50% decline in ICAM-2 signal strength after 24 hours of LPS
stimulation.20
Although this level of change approaches
the sensitivity limits of this assay (Atlas Arrays; Clontech), it
suggests that ICAM-2 mRNA declines after EC activation. By contrast to
the clear constitutive expression of ICAM-1 and -2, negligible VCAM-1
and no E-selectin expression were detectable in unstimulated HIECs, at
both the mRNA and protein levels. As with ICAM-1, both VCAM-1 and
E-selectin are potently upregulated in iris ECs when activated by
inflammatory stimuli, in line with their previously suspected roles in
uveitis.21
22
23
24
25
26
Unlike the persistent ICAM-1 elevation,
VCAM-1 and E-selectin upregulation is transient.
The activated phenotype of HIECs was reflected at the functional level, wherein LPS-stimulated HIECs showed a significantly increased adhesiveness for U937 monocytes. This effect was in part blocked by the preincubation of HIECs with neutralizing antibodies against various adhesion molecules (i.e., ICAM-1 and -2 and VCAM-1). This is consistent with a demonstrated role for EC-expressed ICAM-1 in mediating ocular inflammation in both animal models and clinical investigations,15 21 22 23 24 25 and suggests that these cultured HIECs can qualitatively mimic the in vivo scenario. Previously, immunohistology performed on iris biopsy specimens from patients with either acute or chronic AU has revealed upregulated expression of ICAM-1 and VCAM-1 on human iris microvascular ECs, implicating both adhesion molecules in the increased leukocyte flux through the iris in AU.24 25 26 Our current data support this likelihood.
To date, this is the first report of an investigation of the role of
ICAM-2 in ocular inflammation. Although ICAM-2 was appreciably
downregulated in activated HIECs, as has been reported in TNF
- and
IL-1ßstimulated umbilical vein ECs,27
we observed that
it nonetheless remained present in sufficient amounts to significantly
mediate the binding of leukocytes to these vascular cells. Endothelial
ICAM-2 is known to support the adhesion of a variety of leukocyte
subsets to ECs, by acting as a ligand for the leukocyte-specific
ß2 integrins, LFA-1 and
Mac-1,28
29
and appears to be essential for T-cell
transendothelial migration. Of note, peptide fragments of ICAM-2 and
soluble ICAM-2/Fc chimeras can bind to and rapidly enhance the affinity
of these leukocyte integrins for both ICAM-1 and -2, resulting in a
feed-forward enhancement of adhesion.30
Soluble ICAM-1 is
present in normal human plasma in nanogram-per-milliliter quantities,
and circulating levels are significantly increased in a variety of
inflammatory disorders, including uveitis.31
32
In addition, soluble adhesion molecules, including ICAM-1, are elevated in the aqueous humor of eyes with uveitis32 and in the vitreous of eyes with proliferative diabetic retinopathy and proliferative vitreoretinopathy.33 Very recently, soluble ICAM-2 has been detected in the bloodstream of normal humans and patients with leukemia, with concentrations significantly lowered after chemotherapeutic reduction of circulating leukemic cells (Gahmberg et al. personal communication, 2001). Although currently speculative, if cleavage or shedding of membrane ICAM-2 accompanies its downregulation in activated HIECs, the resultant increased local levels of soluble ICAM-2 may perpetuate inflammation in the iris by activating integrins on nearby leukocytes.30 Taken together with prior experimental observations, our current data suggest a potentially important role for ICAM-2 in mediating leukocyte infiltration in uveitis and warrant further experimentation to this end.
Endothelial expression of various chemokines, cytokines, and cell adhesion molecules are critical determinants in the development of the inflammation in AU. Determination of the EC expression profiles of these molecules and their relative importance in clinical uveitis is difficult because experimental analysis of patients with AU is limited to small samples of aqueous humor or iris biopsy specimens obtained from those undergoing ocular surgery. In addition, anti-inflammatory pharmacologic regimens are often under way in these patients and can complicate interpretation of findings. To circumvent these limitations while still working in a relevant human model, cultured HIECs provide a versatile means to expand our understanding of the mechanistic origins of AU. Although cell culture systems are not without inherent experimental limitations, this approach complements the existing animal models and clinical investigations in together elucidating the molecular mechanisms of uveitis.
| Acknowledgements |
|---|
| Footnotes |
|---|
Presented in part in a poster session at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2, 2000.
Supported by National Eye Institute Grants EY06477, EY06484, and EY10572; by Research to Prevent Blindness awards (JTR, SRP, and the Casey Eye Institute); by Tartar Trust Research Fellowship grants, Oregon Science Foundation, Portland (MDS, DOZ); and by a Retina Research Foundation Fellowship Award (MDS).
Submitted for publication February 23, 2001; revised July 9, 2001; accepted July 30, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: Stephen R. Planck, Oregon Health Sciences University, Mail Code CEI-RES, 3375 SW Terwilliger Boulevard, Portland, OR 97201-4197. plancks{at}ohsu.edu
| References |
|---|
|
|
|---|
response elements in the human ICAM-2 promoter J Cell Sci 112,4695-4703[Abstract]
This article has been cited by other articles:
![]() |
A C Browning, T Gray, and W M Amoaku Isolation, culture, and characterisation of human macular inner choroidal microvascular endothelial cells Br. J. Ophthalmol., October 1, 2005; 89(10): 1343 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Kim, Z. Li, R. N. Fariss, D. F. Shen, S. P. Mahesh, C. Egwuagu, C.-R. Yu, C. N. Nagineni, C.-C. Chan, and R. B. Nussenblatt Constitutive and Cytokine-Induced GITR Ligand Expression on Human Retinal Pigment Epithelium and Photoreceptors Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3170 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Schultz, M. L. Klein, A. J. Humpert, C. W. Luzier, V. Persun, M. Schain, A. Mahan, C. Runckel, M. Cassera, V. Vittal, et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family Hum. Mol. Genet., December 15, 2003; 12(24): 3315 - 3323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Silverman, D. O. Zamora, Y. Pan, P. V. Texeira, S.-H. Baek, S. R. Planck, and J. T. Rosenbaum Constitutive and Inflammatory Mediator-Regulated Fractalkine Expression in Human Ocular Tissues and Cultured Cells Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1608 - 1615. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |